Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 16, 2007
Patent Application Number
10442894
Date Filed
May 20, 2003
Patent Primary Examiner
Patent abstract
NGF microencapsulation compositions having controlled release characteristics, preferably with increased stability, for the NGF component, particularly human recombinant NGF (“rhNGF”) are provided that yield enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function. Methods for making and using such compositions are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
